World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
91
Citations
33510
World Ranking
11681
National Ranking
164

Overview

Susana Puig is affiliated with the University of Barcelona in Spain. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a focus on Oncology, Dermatology, Epidemiology, Molecular Biology, and Immunology.

The scientist's work centers on topics such as Cutaneous Melanoma Detection and Management, Nonmelanoma Skin Cancer Studies, Melanoma and MAPK Pathways, Cancer Immunotherapy and Biomarkers, Skin Protection and Aging, Cutaneous lymphoproliferative disorders research, and CAR-T cell therapy research.

Susana Puig has published extensively in academic venues, frequently contributing to:

  • Journal of the European Academy of Dermatology and Venereology
  • EJC Skin Cancer
  • Actas Dermo-Sifiliográficas
  • Journal of the American Academy of Dermatology
  • British Journal of Dermatology

Their recent papers include:

  • "Human-computer collaboration for skin cancer recognition," 2020, Nature Medicine
  • "Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo," 2020, JAMA Oncology
  • "Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma," 2022, Nature Medicine
  • "Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial," 2021, The Lancet Oncology
  • "Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial," 2020, Journal of Clinical Oncology

Their frequent co-authors include:

  • Josep Malvehy
  • Cristina Carrera
  • Sebastián Podlipnik
  • Javiera Pérez-Ánker
  • Élisa Cinotti

Best Publications

  • Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma

    Alexander M.M. Eggermont;Christian U. Blank;Mario Mandala;Georgina V. Long

  • Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet

    Giuseppe Argenziano;H.Peter Soyer;Sergio Chimenti;Renato Talamini

  • A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma

    Corine Bertolotto;Fabienne Lesueur;Sandy Giuliano;Thomas Strub

  • Human–computer collaboration for skin cancer recognition

    Philipp Tschandl;Christoph Rinner;Zoe Apalla;Giuseppe Argenziano

  • Genome-wide association study identifies three loci associated with melanoma risk.

    D Timothy Bishop;Florence Demenais;Mark M Iles;Mark Harland

  • Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma‐prone families from three continents

    Alisa M Goldstein;May Chan;Mark Harland;Nicholas K Hayward

  • High-risk Melanoma Susceptibility Genes and Pancreatic Cancer, Neural System Tumors, and Uveal Melanoma across GenoMEL

    Alisa M. Goldstein;May Chan;Mark Harland;Elizabeth M. Gillanders

  • A DNA methylation fingerprint of 1628 human samples

    Augustin F. Fernandez;Yassen Assenov;Jose Ignacio Martin-Subero;Balazs Balint

  • Comparison of the accuracy of human readers versus machine-learning algorithms for pigmented skin lesion classification: an open, web-based, international, diagnostic study.

    Philipp Tschandl;Noel Codella;Bengü Nisa Akay;Giuseppe Argenziano

  • Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo: A Secondary Analysis of a Randomized Clinical Trial

    Alexander M.M. Eggermont;Michal Kicinski;Christian U. Blank;Mario Mandala

  • Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

    Alexander M M Eggermont;Christian U Blank;Mario Mandalà;Georgina V Long

  • Dermoscopy Improves Accuracy of Primary Care Physicians to Triage Lesions Suggestive of Skin Cancer

    Giuseppe Argenziano;Susana Puig;Iris Zalaudek;Francesco Sera

  • Dermoscopic evaluation of amelanotic and hypomelanotic melanoma

    Menzies Sw;Kreusch J;Byth K;Pizzichetta Ma

  • Prevalence of psoriasis in Spain (Epiderma Project: phase I)

    C Ferrándiz;Bordas X;García-Patos;S Puig

  • Genome-wide association study identifies three new melanoma susceptibility loci

    Jennifer H. Barrett;Mark M. Iles;Mark Harland;John C. Taylor

  • Entodermoscopy: a new tool for diagnosing skin infections and infestations.

    Iris Zalaudek;Jason Giacomel;Horacio Cabo;Alessandro Di Stefani

  • Dermoscopy of Bowen's disease.

    I. Zalaudek;G. Argenziano;B. Leinweber;L. Citarella

  • Standardization of terminology in dermoscopy/dermatoscopy: Results of the third consensus conference of the International Society of Dermoscopy.

    Harald Kittler;Ashfaq A. Marghoob;Giuseppe Argenziano;Cristina Carrera

  • Confirmation of a double-hit model for the NF1 gene in benign neurofibromas.

    Eduard Serra;Susana Puig;David Otero;Antonia Gaona

  • BCN20000: Dermoscopic Lesions in the Wild.

    Marc Combalia;Noel C. F. Codella;Veronica Rotemberg;Brian Helba

Frequent Co-Authors

Josep Malvehy
Josep Malvehy University of Barcelona
Giuseppe Argenziano
Giuseppe Argenziano University of Campania "Luigi Vanvitelli"
Iris Zalaudek
Iris Zalaudek University of Trieste
Ashfaq A. Marghoob
Ashfaq A. Marghoob Memorial Sloan Kettering Cancer Center
Giovanni Pellacani
Giovanni Pellacani Sapienza University of Rome
Nelleke A. Gruis
Nelleke A. Gruis Leiden University Medical Center
Nicholas K. Hayward
Nicholas K. Hayward QIMR Berghofer Medical Research Institute
Alisa M. Goldstein
Alisa M. Goldstein National Institutes of Health
Johan Hansson
Johan Hansson Karolinska Institute
Graham J. Mann
Graham J. Mann Australian National University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine in the USA offers many online degree options for students seeking flexible routes to a healthcare career. Aspiring nurses, nurse practitioners, and healthcare professionals can benefit from a variety of accelerated and fast-track online programs.

For registered nurses aiming for leadership or advanced clinical roles, accelerated dnp programs online provide the opportunity to earn a Doctor of Nursing Practice degree more quickly. Those looking for easier study paths can explore easiest dnp programs that offer flexible schedules and less intensive coursework.

Students interested in starting their careers quickly can consider fast track medical training programs, including Licensed Practical Nurse (LPN) courses that can be completed in shorter timeframes. Additionally, for those holding a master’s degree, shortest post master's pmhnp online programs allow for specialization as a Psychiatric Mental Health Nurse Practitioner in an accelerated format.

Exploring these online options can open new career pathways in medicine, providing greater flexibility and faster entry into the healthcare workforce.

Best Scientists Citing Susana Puig

Trending Scientists

Recently Published Articles